People 50 and older should get pneumococcal vaccine, US science panel recommends The Associated PressCDC panel lowers age for key vaccine. What older adults should know. USA TODAYCDC vaccine advisers recommend second COVID vaccine dose for seniors, immune-compromised cidrap.umn.eduCDC Panel Favors Wider Use of Pfizer, Merck Pneumococcal Shots (PFE, MRK) BloombergCDC’S ACIP Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older Yahoo Finance